Veru - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsVeru

Veru(VERU)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

breast neoplasms

,

triple negative breast neoplasms

,

muscular atrophy

,

,

mobility limitation

,

breast neoplasms

Aglatimagene besadenovec

prostatic hyperplasia

,

,

lower urinary tract symptoms

breast neoplasms

,

respiratory distress syndrome

,

acute lung injury

,

newborn respiratory distress syndrome

,

,

triple negative breast neoplasms

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

severe acute respiratory syndrome

,

,

prostatic neoplasms

healthy volunteers/patients

,

glycemic control

,

,

,

,

colorectal neoplasms

,

colonic neoplasms

,

rectal neoplasms

,

head and neck neoplasms

,

squamous cell carcinoma of head and neck

,

hyperinsulinism

,

,

neuroendocrine tumors

,

neoplasm metastasis

,

carcinoid tumor

,

islet cell carcinoma

,

,

chronic renal insufficiency

,

glucose metabolism disorders

,

endocrine system diseases

,

,

cardiovascular diseases

,

chronic obstructive pulmonary disease

,

,

,

,

,

,

,

kidney diseases

,

type 2 diabetes mellitus

,

diabetes mellitus

,

type 1 diabetes mellitus

,

insulin resistance

,

,

metabolic diseases

,

,

metabolic syndrome

,

gestational diabetes

,

myocardial infarction

,

inferior wall myocardial infarction

,

psychotic disorders

,

prediabetic state

,

disease progression

,

,

patient participation

,

diabetic neuropathies

,

glucose intolerance

healthy volunteers/patients

,

glycemic control

,

,

,

,

colorectal neoplasms

,

colonic neoplasms

,

rectal neoplasms

,

head and neck neoplasms

,

squamous cell carcinoma of head and neck

,

hyperinsulinism

,

,

neuroendocrine tumors

,

neoplasm metastasis

,

carcinoid tumor

,

islet cell carcinoma

,

,

chronic renal insufficiency

,

glucose metabolism disorders

,

endocrine system diseases

,

,

cardiovascular diseases

,

,

chronic obstructive pulmonary disease

,

,

,

,

,

,

kidney diseases

,

type 2 diabetes mellitus

,

diabetes mellitus

,

type 1 diabetes mellitus

,

insulin resistance

,

,

metabolic diseases

,

,

metabolic syndrome

,

gestational diabetes

,

myocardial infarction

,

inferior wall myocardial infarction

,

psychotic disorders

,

prediabetic state

,

disease progression

,

,

patient participation

,

diabetic neuropathies

,

glucose intolerance

breast neoplasms

Enclomiphene citrate

,

ovarian hyperstimulation syndrome

,

pharmacokinetics

,

substance-related disorders

,

healthy volunteers/patients

,

drug interactions

,

therapeutic equivalency

,

renal insufficiency

,

,

endocrine system diseases

,

,

type 2 diabetes mellitus

,

gonadal disorders

,

uterine hemorrhage

,

hyperprolactinemia

,

opioid-related disorders

,

,

prostatic neoplasms

,

diabetes mellitus

,

,

rotator cuff injuries

,

,

teratozoospermia

,

premature birth

,

premature menopause

,

,

neoplasm metastasis

,

,

hyperandrogenism

,

,

,

spontaneous abortion

,

gestational diabetes

,

,

,

assisted reproductive techniques

,

,

polycystic ovary syndrome

,

,

,

female infertility

,

ovulation induction

,

male infertility

,

,

,

primary ovarian insufficiency

,

vitamin d deficiency

,

insulin resistance

,

,

fertilization in vitro

,

treatment-resistant depressive disorder

,

,

hyperinsulinism

,

,

,

ectopic pregnancy

,

,

asymptomatic diseases

,

,

colorectal neoplasms

,

breast neoplasms

,

ovarian neoplasms

,

endometrial neoplasms

,

thyroid neoplasms

,

hypersensitivity

,

pathologic processes

,

pregnancy outcome

,

time-to-pregnancy

,

,

dry eye syndromes

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use